Loading...
XAMS
DSFIR
Market cap24bUSD
Jul 28, Last price  
83.44EUR
1D
1.96%
1Q
31.69%
IPO
-30.26%
Name

DSM-Firmenich AG

Chart & performance

D1W1MN
XAMS:DSFIR chart
P/E
P/S
2.28
EPS
Div yield, %
3.07%
Shrs. gr., 5y
8.50%
Rev. gr., 5y
2.19%
Revenues
9.03b
-29.42%
8,858,000,0007,051,000,0007,722,000,0007,920,000,0008,632,000,0009,267,000,0007,998,000,0008,106,000,00011,444,000,0008,390,000,00010,627,000,00012,799,000,0009,034,000,000
Net income
-1.08b
L
252,000,000123,000,000174,000,000645,000,0001,761,000,0001,069,000,000675,000,000448,000,000872,000,000460,000,0002,137,000,000250,000,000-1,081,000,000
CFO
1.39b
-21.93%
998,000,000808,000,000696,000,0001,018,000,000996,000,0001,391,000,0001,385,000,0001,494,000,0001,427,000,000923,000,0001,265,000,0001,778,000,0001,388,000,000
Dividend
May 11, 20262.5 EUR/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

DSM-Firmenich AG provides nutrition, health, and beauty solutions in Switzerland, the Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia. The company operates through four segments: Perfumery & Beauty; Taste, Texture & Health; Health, Nutrition & Care; and Animal Nutrition & Health. The Perfumery & Beauty creates scents using natural, synthetic, and biotech ingredients. The Taste, Texture & Health segment provides food and beverages solutions, including flavors, natural extracts, and sugar reduction; and food enzymes, hydrocolloids, cultures, natural colorants, nutritional ingredients, and plant-based proteins. The Health, Nutrition & Care segment provides solutions for the early life nutrition, dietary supplement, pharmaceutical, medical nutrition, biomedical materials, and nutrition improvement markets. This segment also offers vitamins, nutritional lipids, minerals, carotenoids, botanical nutraceuticals, digestive enzymes, postbiotics, probiotics and prebiotics, and active pharmaceutical ingredients; biomedical solutions; and premix, market-ready, and personalized nutrition solutions, as well as expert services in regulatory affairs and nutrition. The Animal Nutrition & Health segment offers animal proteins, vitamins, performance solutions, and data-driven precision services. The company was founded in 1902 and is based in Kaiseraugst, Switzerland.
IPO date
Apr 18, 2023
Employees
29,306
Domiciled in
CH
Incorporated in
CH

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT